[A controlled study on the treatment of tardive dyskinesia using 1-stepholidine]
- PMID: 3069384
[A controlled study on the treatment of tardive dyskinesia using 1-stepholidine]
Similar articles
-
[Clinical study on the treatment of dyskinesia by L-stepholidine].Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1989 Dec;22(6):335-7, 381-2. Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1989. PMID: 2700694 Clinical Trial. Chinese.
-
Berberine in trachoma. (A clinical trial).Indian J Ophthalmol. 1982 Mar;30(2):69-75. Indian J Ophthalmol. 1982. PMID: 6754599 Clinical Trial. No abstract available.
-
[1-SPD, a new dopamine receptors blocker, in treating vascular headache].Zhonghua Nei Ke Za Zhi. 1987 Dec;26(12):681-4, 741. Zhonghua Nei Ke Za Zhi. 1987. PMID: 3451849 Chinese. No abstract available.
-
Recent developments in studies of l-stepholidine and its analogs: chemistry, pharmacology and clinical implications.Curr Med Chem. 2007;14(28):2996-3002. doi: 10.2174/092986707782794050. Curr Med Chem. 2007. PMID: 18220736 Review.
-
Vitamin E in tardive dyskinesia.Ann Pharmacother. 1993 Mar;27(3):311-3. Ann Pharmacother. 1993. PMID: 8453169 Review. No abstract available.
Cited by
-
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD000459. doi: 10.1002/14651858.CD000459.pub3. Cochrane Database Syst Rev. 2018. PMID: 29409162 Free PMC article.
-
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD000208. doi: 10.1002/14651858.CD000208.pub2. Cochrane Database Syst Rev. 2018. PMID: 29552749 Free PMC article.